Mr. Speaker, from time to time we have an opportunity to discuss an issue that is so fundamentally important that the question of action is not if, but how.
Before us today is a bill that will address the ongoing and terribly destructive crisis with access to medicines in developing and least developed countries across the world. While this bill is not perfect, there is a balance to be struck between maintaining our country's commitment to intellectual property protection while ensuring that we do not build unnecessary barriers limiting access to the medicines that are much needed in developing countries. That is why it is important to get this legislation to committee for closer examination.
We have no excuse for inaction. The House already passed a version of this bill in the last Parliament and the problem is not going away. It has been eight years since the Liberal government of the day put forward a bill that established a legal framework for Canada's access to medicine regime. The bill, otherwise known as Jean Chrétien's pledge to Africa act, was meant to create a balance between addressing our commitment to combat HIV and AIDS and simultaneously honouring intellectual property rights and trade obligations. The bill passed unanimously. Through that legislation, parliamentarians of all stripes signalled that it was a priority that there be timely access to affordable generic versions of patented drugs meant to fight HIV-AIDS, malaria, tuberculosis and other diseases that are killing thousands of vulnerable men, women and children every day. As an international leader, we could not stand idly by and watch others suffer without trying to help.
It has since become clear that the bill, well-intentioned as it was, proved ineffective in accomplishing its main role. Whether it has been overly complex or onerous or unresponsive to the urgent needs of countries in need, Canada's access to medicines regime has simply not lived up to its intended purpose. That is not to say that we should throw the baby out with the bathwater. There are solutions and we must move forward to implement them and reach these noble goals.
The bill before us today contains workable solutions to the administrative burdens that have made CAMR frustratingly inaccessible. In fact, we saw this legislation before the last Parliament as Bill C-393, and the House of Commons passed it before it died in the Senate when Parliament was dissolved for a general election.
I remember its passage from the House as one of the proudest moments in my time here, standing with a majority of fellow members, Liberals, NDP, the Bloc and several Conservatives alike saying to the world that we would help. At that time I argued that we could, and I still firmly believe that we can, pass this legislation and prolong lives while preventing the transmission of insidious diseases like HIV-AIDS. We can renew a lease on life for ailing parents, confident in the knowledge that they can live to provide for their loved ones, secure in knowing that they will not transmit the disease to their children. It is not enough to wish it were so, and words certainly will not make it true. Action is necessary. We can act now and finally address this head on.
Mr. Speaker, I will defer to you, understanding that I will have six minutes remaining when called upon again.